CoChat
Sign Up
Cited by 4Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentPharmaceutical Practices and Patient Outcomes

Benzodiazepines Dependence: Addiction to Legally Prescribed Substances

Open access
S. Anna Gandra, Sofia, D Almeida, Agostinho Leite, M. Teixeira, Zelia·2019·Journal of Forensic Psychology
DOI 10.35248/2475-319x.19.4.149
Open this paper in CoChat — free accountOpen PDF

Abstract

The undue use of benzodiazepines can lead to dependence of this substance, constituting a serious health problem, hard to manage therapeutically. Despite this finding, the prescription of benzodiazepines is still common. In the literature there are several proposals for therapeutic intervention, ranging from the gradual reduction to the psychotherapeutic intervention. In view of the above, this review of the literature aims to understand the specific theme of addition to benzodiazepines. With the present study, we highlight the impact that this dependence has on individuals’ lives, the difficulty of withdrawing these substances, and the lack of adequate responses in the national health system to deal with the problem. We came to the conclusion that the psychotherapeutic intervention is extremely important for the treatment of this phenomenon and that the prevention of these situations must be a priority.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.35248/2475-319x.19.4.149

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 44 · Cited by 4

Research works printed but not linked: 40

  1. Lopes R, Yaphe J, Ribas MJ. Prescrição de psicofármacos nos cuidados de saúde primários no Porto: estudo transversal. Revista Portuguesa de Medicina Geral e Familiar. 2014;30:368- 376.
  2. Donoghue J, Lader M. Usage of benzodiazepines: A review. Int J Psychiatry Clin Pract. 2010;14:78-87.
  3. Fresán A, Minaya O, Cortés-López JL, Ugalde O. Características demográficas y clínicas associadas a la dependencia a benzodiacepinas en pacientes psiquiátricos. Salud Mental. 2011;34:103-109.
  4. Lader M. Benzodiazepines revisited-will we ever learn? Addiction. 2011;106:2086-2109.
  5. Manthey L, Lohbeck M, Giltay EJ, Van Veena T, Zitman FG. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety. Addiction. 2012;107:2173- 2182.
  6. Quaglio G, Pattaro C, Gerra G, Mathewson S, Verbanck P, Des Jarlais DC, et al. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam. Psychiatry Res. 2012;198:457-462.
  7. Correia DT, Guerreiro DF, Barbosa A. Semiologia psicopatológica. Em D.T. Correia (Ed.), Manual de psicopatologia: De acordo com o DSM-5 (2ª ed., pp.19-91). Lisboa: Lidel -Edições Técnicas, Lda, 2014.
  8. Dugas MJ, Brillon P, Savard P, Turcotte J, Gaudet A. A randomized clinical trial of cognitive-behavioral therapy and applied relaxation for adults with generalized anxiety disorder. Behavior Therapy. 2010;41: 46-58.
  9. Galperyn K, Crockford D, El-Guebaly N. Understanding cognitive behavioural therapy for addiction: Its use in tapering off benzodiazepines. Can J Addict Med. 2014;5:13-15.
  10. Moriana JA, Gálvez-Lara M, Corpas J. Psychological treatments for mental disorders in adults: A review of the evidence of leading international organizations. Clin Psychol Rev. 2017;54:29-43.
  11. Bagby RM, Psych C, Quilty LC, Ryder AC. Personality and depression. Can J Psy. 2008;53:14-25.
  12. Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK. Benzodiazepine dependence and its treatment with low dose flumazenil. Br J Clin Pharmacol. 2012;77:285-294.
  13. Konopka A, Pełka-Wysiecka J, Grzywacz A, Samochowiec J. Psychosocial characteristics of benzodiazepine addicts compared to not addicted benzodiazepine users. Prog Neuro- Psychopharmacol Biol Psychiatry. 2013;40: 229-235.
  14. Longo LP, Johnson B. Addiction: Part I. Benzodiazepines -side effects, abuse risk and alternatives. Am Fam Physician. 2000;61:2121-2128.
  15. Salzman C. Addiction to benzodiazepines. Psychiatric Quarterly. 1998;69: 251-261.
  16. Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Australian Prescriber. 2015;38:152-155.
  17. Coutinho D, Vieira DN, Teixeira HM. Condução sob influência de benzodiazepinas e antidepressivos prescrição médica e abuso. Acta Médica Portuguesa. 2011;24:431-438.
  18. Gérardin M, Victorri-Vigneau C, Guerlais M, Guillou-Landreat M, Grall-Bronnec M, Jolliet P. Benzodiazepines consumption: Does dependence vary with age? Substance Use & Misuse. 2014;49:1417-1425.
  19. Liebrenz M, Schneider M, Buadze A, Gehring MT, Dube A, Caflisch C. Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study. Harm Reduction Journal. 2016;13:1-10.
  20. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166:1092-1097.
  21. In-Albon T, Schneider S. Psychotherapy of childhood anxiety disorders: A meta-analysis. Psychother Psychosom. 2007;76:15- 24.
  22. Reynolds S, Wilson C, Austin J, Hooper L. Effects of psychotherapy for anxiety in children and adolescents: A meta- analytic review. Clin Psychol Rev. 2012;32:251-262.
  23. Ashworth M, Gerada C, Dallmeyer R. Benzodiazepines: addiction and abuse. Drugs: education, prevention and policy. 2002;9:389-397.
  24. Cuevas C, Sanz E, Fuente J. Benzodiazepines: More "behavioural" addiction than dependence. Psychopharmacology. 2003;167:297-303.
  25. Rosas-Gutiérrez I, Simón-Arceo K, Mercado F. Mecanismo celular y molecular de la adicción a benzodiacepinas. Salud Mental. 2013;36:325-329.
  26. Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008;90:74-89.
  27. Zandstra S, Furer J, Van de Lisdonk E, Bor J, Zitman F, Van Weel C. Differences in health status between long-term and short term benzodiazepine users. Br J Gen Pract. 2002;52:805- 808.
  28. Breggin PR. Analysis of adverse behavioral effects of benzodiazepines with a discussion on drawing scientific conclusions from the FDA's spontaneous reporting system. The J Mind and Behav. 1998;19:21-50.
  29. Bogunovic OJ, Greenfield SF. Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatric Services. 2004;55:233-235.
  30. Ghitza UE, Epstein DH, Preston KL. Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug Alcohol Depend. 2008;97:150-157.
  31. Miranda JA. Benzodiazepinas: Usos e abusos. Rev Port Clin Geral. 2000;16:355-357.
  32. Zandstra SM, Van Rijswijk E, Rijndersa C, Van de Lisdonk EH, Bor JHJ, Van Weel C, et al. Long-term benzodiazepine users in family practice: differences from short-term users in mental health, coping behavior and psychological characteristics. Family Practice. 2004;21:266-269.
  33. Hernandez SH, Nelson LS. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther. 2010;88:307-317.
  34. Ouzir M, Errami M. Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. Pharmacol Biochem Behav. 2016;148:59-68.
  35. Wise RA. Brain reward circuitry: Insights from unsensed incentives. Neuron. 2002;36:229-240.
  36. Tam C, Foo Y. Contributory factors of drug abuse and the accessibility of drugs. Int J Collab Res Intern Med Public Health. 2012;4:1621-1625.
  37. Góis M, Amaral J. O uso de drogas lícitas e ilícitas e suas consequências sociais e económicas. ETIC -Encontro de Iniciação Científica. 2010;5:1-22.
  38. Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, et al. Benzodiazepines dependence: focus on withdrawal syndrome. Ann Pharm Fr. 2009;67:408-413.
  39. Bueno JR. Emprego clínico, uso indevido e abuso de benzodiazepínicos -Uma revisão. Debates em Psiquiatria. 2012;3:6-11.
  40. Ashton H. The treatment of benzodiazepine dependence. Addiction. 1994;89:1535-1541.

Authors
S. Anna Gandra, S., D Almeida, A. L., & M. Teixeira, Z.
Venue
Journal of Forensic Psychology
Publisher
Longdom Group
Published
2019
Volume
04
Issue
02
ISSN
2475-319X (ISSN-L)
DOI
10.35248/2475-319x.19.4.149
OpenAlex
W2966515004
Cited by
4
References
44
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2021: 1
FWCI
0.38
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
Journal of Forensic Psychology (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
benzodiazepine dependence, prescription drug misuse, benzodiazepine withdrawal, psychotherapeutic interventions, gradual dose reduction, addiction prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review